Clofibrate and tiadenol treatment in hyperlipoproteinemias
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 49 (2) , 149-161
- https://doi.org/10.1016/0021-9150(83)90192-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Pharmacological studies on tiadenol in type IV patients Evidence for a mechanism of action different from other lipid-lowering drugsAtherosclerosis, 1981
- The role of lipoprotein lipase in the assimilation of cholesteryl linoleyl ether by cultured cells incubated with labeled chylomicronsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Fenofibrate therapy of hyperlipoproteinaemia a dose—response study and a comparison with clofibrateAtherosclerosis, 1981
- Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrationsAtherosclerosis, 1980
- Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy.Circulation, 1979
- Increased plasma cholesterol and decreased body lipid levels in wistar rats following pirinixil (BR 931) treatmentPharmacological Research Communications, 1979
- The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemiaAtherosclerosis, 1977
- Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemiaMetabolism, 1977
- Clofibrate Reversal of Platelet Hypersensitivity in HyperbetalipoproteinemiaCirculation, 1974
- Hypocholesterolemic agents and mobilization of tissue cholesterol in manAtherosclerosis, 1973